Co-Founder Geoffrey Tabin, MD, Professor of Ophthalmology & Visual Sciences, Director, Division of International Ophthalmology, John A. Moran Eye Center, University of Utah, Utah, USA.
Co-Founder Sanduk Ruit, MD, Medical Director, Tilganga Eye Centre, Kathmandu, Nepal.
Board of Directors
Farran Tozer Brown, MBA, New York Landmark Conservancy, Member of Advisory Council.
Independent Board Member. Joined Board of Directors April 2014. Current term to expire November 2019.
Adrienne Graves, PhD, Independent Director, Akorn Inc, TearLab Corporation, Aerpio Therapeutics, and EncoreVision. Past President and CEO, Santen Inc., California, USA.
Independent Board Member. Joined Board of Directors February 2013. Current term to expire November 2018.
Stewart Halpern, Board Member, Advisor, Angel Investor, PT Exec.
Independent Board Member. Joined Board of Directors October 2014. Current term to expire November 2019.
Matthew Oliva, MD, Associate Clinical Professor, Division of International Ophthalmology, Casey Eye Institute, Oregon Health Sciences University and Private Practice Ophthalmologist, Oregon, USA.
Independent Board Member. Joined Board of Directors November 2007. Current term to expire November 2017.
Randall Olson, MD, Professor and Chairman; Director, John A. Moran Eye Center, University of Utah, Utah, USA.
Independent Board Member. Joined Board of Directors October 2005. Current term to expire November 2019.
Chair, Geoffrey Tabin, MD, Professor of Ophthalmology & Visual Sciences, Director, Division of International Ophthalmology, John A. Moran Eye Center, University of Utah, Utah, USA.
Independent Board Member. Joined Board of Directors September 1999. Current term to expire November 2019.
Further Background on Board Members
Adrienne Graves, PhD
Adrienne L. Graves, Ph.D. is a visual scientist by training and a global industry leader in ophthalmology. From 2002 to 2010, Dr. Graves was President and Chief Executive Officer of Santen Inc., the US arm of Japan's largest ophthalmic pharmaceutical company. She joined Santen in 1995 as VP of Clinical Affairs to initiate clinical development in the US, and was responsible for 3 NDA approvals. She was promoted to Sr. VP of Worldwide Clinical Affairs (Japan, US, and Europe), and was subsequently named a global Corporate Officer and CEO of US operations. Prior to joining Santen, Dr. Graves spent nine years with Alcon Laboratories, Inc., beginning in 1986 as a Senior Scientist. She progressed through various roles, including Director of International Ophthalmology. Dr. Graves currently serves as an Independent Director on the following corporate boards: Akorn, Inc., TearLab Corporation, Aerpio, and Encore Vision. She is also a Director on the following Foundation Boards: American Society of Cataract and Refractive Surgery (ASCRS) Foundation, Glaucoma Research Foundation, American Academy of Ophthalmology (AAO) Foundation (Emeritus), Himalayan Cataract Project, Pan-American Ophthalmology Foundation, and KeepYourSight Foundation; she also serves on the Corporation Committee for the Brown University Medical School and the Advisory Board for Amach Capital Partners. Dr. Graves cofounded Glaucoma 360 and Ophthalmic Women Leaders (OWL). She received her AB in Psychology with honors from Brown University, her PhD in Psychobiology from the University of Michigan, and she completed a postdoctoral fellowship in visual neuroscience at the University of Paris.
Stewart A. Halpern
Stewart A. Halpern is a financial executive with over 30 years of experience as a Chief Financial Officer of public and private companies and as an equity analyst and investment banker with several major Wall Street firms. He is currently Senior Advisor and a member of the Board of Directors of Roovy, Inc., an early-stage San Diego-based company. Previously he served as the Chief Financial Officer for Mad Catz Interactive, videogame publisher Rockstar Games, and entertainment entrepreneur Russell Simmons’ Rush Communications. Mr. Halpern began his career as an investment banker at Credit Suisse First Boston, and later was a Institutional Investor-ranked sellside equity analyst at ING Furman Selz, Banc of America Securities and RBC Capital Markets. From 1991-1992 he served as Advisor to the Ministry of Privatization of Czechoslovakia. Mr. Halpern currently is a member of the Board of Directors of several other non-profit organizations: environmental advocacy group San Diego Coastkeeper, where he serves as the Board's Treasurer and a member of the Executive Committee; America's Finest Charter School (San Diego, CA), where he will assume the presidency of the Board later this year; and the Free Flight Exotic Bird Sanctuary (Del Mar, CA), where he serves as the Board's Treasurer. In 2014 Mr. Halpern was appointed to serve on the Independent Taxpayers Oversight Committee of the San Diego Association of Governments. He received his BS in Administrative Sciences with honors from Yale College and a Masters in Public and Private Management from the Yale School of Management.
Matthew Oliva, MD
Dr. Oliva is Associate Clinical Professor in the Division of International Ophthalmology at Casey Eye Institute and Oregon Health Sciences University and he is a private practice ophthalmologist in Medford, Oregon.
Randall Olson, MD
Dr. Olson is Professor and Chairman of Ophthalmology & Visual Sciences at the University of Utah School of Medicine and Director of the John A. Moran Eye Center at the University of Utah. He is one of the most respected and noted ophthalmologists in the country with a practice focused on all areas of cornea and external disease, as well as other anterior segment disorders. He has a special interest in intraocular lens related complications.